PUBLIC COMPANY
save$CLRBCellectar Biosciences, Inc.
$CLRBFlorham Park, NJ, USupdated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
- phase1Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
- phase1Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas
- phase2Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that